Current Challenges in the Management of persistent or chronic ITP

 

Platelet Disorder Support Association (PDSA)
Avatar

What Makes ITP Refractory

By Platelet Disorder Support Association (PDSA) FEATURING James Bussel
By Platelet Disorder Support Association (PDSA) FEATURING James Bussel
14 views
September 21, 2022
0 Comments
Login to view comments. Click here to Login
Current Challenges in the Management of persistent or chronic ITP
18:26
Moffitt Cancer Center

2L Therapies for Chronic and Persistent ITP

Feat. V. Phuoc
05:00
ASH 2022 Conference Coverage

Cognitive Impairment in Patients With ITP

Feat. C. Vladescu
12:24
Kelsey Martin

Addressing the Management of ITP: Review of the ASH Clinical Practic…

33:35
Platelet Disorder Support Association (PDSA)

The Senior Years: Managing Your ITP

Feat. C. Kessler
20:59
Platelet Disorder Support Association (PDSA)

Blood Clots and ITP Updates

Feat. D. Kuter
12:29
Michael Boxer

Tapering Corticosteroids in ITP and Then What?

15:30
NYU Langone

TPO-RA Agents in Children With ITP: What to Consider in Terms of Tim…

Feat. K. Hillier
19:56
Platelet Disorder Support Association (PDSA)

What Makes ITP Refractory

Feat. J. Bussel
19:58
Platelet Disorder Support Association (PDSA)

New Insights Into What Causes ITP

Feat. J. Semple
23:31
Marc Zumberg

When Steroids Aren't Enough in ITP: Knowing When to Add a TPO-RA

07:15
Weill Cornell Medicine Oncology & Hematology

Eltrombopag in ITP: Learnings From the RAISE and EXTEND Trials

Feat. J. Bussel
24:27
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

ITP: Past and Present

Feat. J. Kelton
28:25
Indy Hematology Review

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Feat. C. Kessler
15:25
Cleveland Clinic Taussig Cancer Institute

Splenectomy for Immune Cytopenias: Treatment Outcomes and Predictors…

Feat. O. Ogbue
11:20
Nicoletta Machin

When Steroids Aren't Enough: Knowing When to Add TPOs to ITP Tr…